Global Tularemia Market Top Players Bayer, Sun Pharmaceutical Industries Ltd, Cipla Inc., Zydus Cadila, LUPIN, GlaxoSmithKline Plc, Glenmark and Pfizer Inc
Global Tularemia Market is accounted for USD 161.5 million in 2016 growing at a CAGR of 3.1% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
View full press release